Clinical Trial Update: Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study [Phase 4]

View source ↗

Summary

A multicenter Phase 4 randomized study in Egyptian women compares low-dose tadalafil with solifenacin for management of overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Overactive Bladder Syndrome

Drugs mentioned

• Solifenacin (solifenacin)
• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Mansoura University | Conditions: Overactive Bladder (OAB), Overactive Bladder Syndrome | Phase 4 | Status: RECRUITING